EXELON CORPORATION financials

EXC CIK 0001109357

Source: EDGAR filings · Built 2026-06-02T02:57:59Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -2.27B -1.53B -2.71B -2.28B -4.97B -3.81B
EBITDA 8.79B 7.92B 7.53B 6.64B 5.71B 5.08B
Working Capital -785.00M -1.23B -1.81B -3.27B -2.15B -209.00M
Net Debt 49.58B 46.42B 43.64B 39.82B 39.65B 39.81B
Operating Margin 21.22% 18.76% 18.52% 17.38% 14.95% 13.15%
Net Margin 11.41% 10.68% 10.71% 11.38% 10.20% 11.73%
Return on Equity (ROE) 9.61% 9.14% 9.04% 8.77% 5.32% 6.00%
Return on Assets (ROA) 2.37% 2.28% 2.29% 2.28% 1.38% 1.51%
Current Ratio 0.92× 0.87× 0.82× 0.69× 0.87× 0.98×
Debt-to-Equity 1.74× 1.74× 1.71× 1.63× 1.17× 1.24×
Effective Tax Rate 15.89% 7.76% 13.84% 14.52% 2.30% -0.64%
Cash Conversion Ratio 2.26× 2.26× 2.02× 2.24× 1.65× 2.17×
Accruals Ratio -0.03× -0.03× -0.02× -0.03× -0.01× -0.02×
CapEx Coverage 0.73× 0.78× 0.63× 0.68× 0.38× 0.53×
Free Cash Flow Per Share $-2.25 $-1.52 $-2.71 $-2.31 $-5.07 $-3.90

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 23.68× 14.98×
EV / EBITDA 10.71× 10.64× 10.56× 12.47× 16.83× 15.94×
P/S 1.84× 1.64× 1.65× 2.25× 3.15× 2.47×
P/B 1.55× 1.41× 1.39× 1.74× 1.64× 1.26×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 24.26B 23.03B 21.73B 19.08B 17.94B 16.66B
Operating Expenses 15.76B 15.26B 14.48B
Operating Income (Loss) 5.15B 4.32B 4.02B 3.31B 2.68B 2.19B
Income Tax Expense (Benefit) 523.00M 207.00M 374.00M 349.00M 38.00M -7.00M
Earnings Per Share, Basic $1.74 $2.01
Weighted Average Number of Shares Outstanding, Basic 1.01B 1.00B 996.00M 986.00M 979.00M 976.00M
Earnings Per Share, Diluted $1.74 $2.01
Weighted Average Number of Shares Outstanding, Diluted 1.01B 1.00B 997.00M 987.00M 980.00M 977.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 626.00M 357.00M 445.00M 407.00M 672.00M 432.00M
Assets, Current 9.55B 8.38B 8.09B 7.34B 13.96B 12.56B
Assets 116.57B 107.78B 101.86B 95.35B 133.01B 129.32B
Long-term Debt 49.43B 44.67B 41.28B 37.17B 38.76B 36.91B
Liabilities, Current 10.33B 9.61B 9.90B 10.61B 16.11B 12.77B
Long-term Debt, Excluding Current Maturities 47.41B 42.95B 39.69B 35.27B 30.75B 35.09B
Liabilities 87.77B 80.86B 76.10B 70.61B 98.22B 94.45B
Stockholders' Equity Attributable to Parent 28.80B 26.92B 25.75B 24.74B 34.39B 32.59B
Common Stock, Shares, Outstanding 1.02B 1.00B 999.00M 994.00M 979.00M 976.00M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 6.25B 5.57B 4.70B 4.87B 3.01B 4.24B
Payments to Acquire Property, Plant, and Equipment 8.53B 7.10B 7.41B 7.15B 7.98B 8.05B
Net Cash Provided by (Used in) Investing Activities -8.53B -7.04B -7.38B -6.99B -3.32B -4.34B
Net Cash Provided by (Used in) Financing Activities 2.53B 1.31B 2.68B 1.59B 758.00M 145.00M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (EXC CIK 0001109357), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

VTGN

Vistagen Therapeutics, Inc.

DX

DYNEX CAPITAL, INC.

NHI

National Health Investors, Inc.